| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3268692 | HPB | 2016 | 9 Pages |
Abstract
Overall survival in patients with lymph node metastases from ICC is poor. Adjuvant therapy was associated with a longer survival in lymph node positive patients, although prospective data are needed. Routine lymphadenectomy should be strongly considered to provide prognostic information and guidance for adjuvant therapy.
Related Topics
Health Sciences
Medicine and Dentistry
Endocrinology, Diabetes and Metabolism
Authors
Zeljka Jutric, W. Cory Johnston, Helena M. Hoen, Pippa H. Newell, Maria A. Cassera, Chet W. Hammill, Ronald F. Wolf, Paul D. Hansen,